Next Article in Journal
The Perverse Impact of External Reference Pricing (ERP): A Comparison of Orphan Drugs Affordability in 12 European Countries. A Call for Policy Change
Previous Article in Journal
Annuity Payments Can Increase Patient Access to Innovative Cell and Gene Therapies under England’s Net Budget Impact Test
 
 
Journal of Market Access & Health Policy (JMAHP) is published by MDPI from Volume 12 Issue 1 (2024). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Taylor & Francis.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Essay

Utilization of Multiple-Criteria Decision Analysis (MCDA) to Support Healthcare Decision-Making FIFARMA, 2016

by
Julia I. Drake
1,*,
Juan Carlos Trujillo de Hart
2,*,
Clara Monleón
3,
Walter Toro
2,4 and
Joice Valentim
5
1
Genentech, Inc, San Francisco, CA, USA
2
FIFARMA, Bogotá, D.C., Colombia
3
JANSSEN, Venezuela, Central America and the Caribbean for JANSSEN, Panama
4
AbbVie, Mettawa, IL, USA
5
Roche Pharma, São Paulo, Brazil
*
Authors to whom correspondence should be addressed.
J. Mark. Access Health Policy 2017, 5(1), 1360545; https://doi.org/10.1080/20016689.2017.1360545
Submission received: 1 January 2017 / Revised: 1 January 2017 / Accepted: 1 January 2017 / Published: 12 October 2017

Abstract

Background and objectives: MCDA is a decision-making tool with increasing use in the healthcare sector, including HTA (Health Technology Assessment). By applying multiple criteria, including innovation, in a comprehensive, structured and explicit manner, MCDA fosters a transparent, participative, consistent decision-making process taking into consideration values of all stakeholders. This paper by FIFARMA (Latin American Federation of Pharmaceutical Industry) proposes the deliberative (partial) MCDA as a more pragmatic, agile approach, especially when newly implemented. Methods: Literature review including real-world examples of effective MCDA implementation in healthcare decision making in both the public and private sector worldwide and in LA. Results and conclusion: It is the view of FIFARMA that MCDA should strongly be considered as a tool to support HTA and broader healthcare decision making such as the contracts and tenders process in order to foster transparency, fairness, and collaboration amongst stakeholders.
Keywords: MCDA; HTA MCDA; HTA

Share and Cite

MDPI and ACS Style

Drake, J.I.; de Hart, J.C.T.; Monleón, C.; Toro, W.; Valentim, J. Utilization of Multiple-Criteria Decision Analysis (MCDA) to Support Healthcare Decision-Making FIFARMA, 2016. J. Mark. Access Health Policy 2017, 5, 1360545. https://doi.org/10.1080/20016689.2017.1360545

AMA Style

Drake JI, de Hart JCT, Monleón C, Toro W, Valentim J. Utilization of Multiple-Criteria Decision Analysis (MCDA) to Support Healthcare Decision-Making FIFARMA, 2016. Journal of Market Access & Health Policy. 2017; 5(1):1360545. https://doi.org/10.1080/20016689.2017.1360545

Chicago/Turabian Style

Drake, Julia I., Juan Carlos Trujillo de Hart, Clara Monleón, Walter Toro, and Joice Valentim. 2017. "Utilization of Multiple-Criteria Decision Analysis (MCDA) to Support Healthcare Decision-Making FIFARMA, 2016" Journal of Market Access & Health Policy 5, no. 1: 1360545. https://doi.org/10.1080/20016689.2017.1360545

APA Style

Drake, J. I., de Hart, J. C. T., Monleón, C., Toro, W., & Valentim, J. (2017). Utilization of Multiple-Criteria Decision Analysis (MCDA) to Support Healthcare Decision-Making FIFARMA, 2016. Journal of Market Access & Health Policy, 5(1), 1360545. https://doi.org/10.1080/20016689.2017.1360545

Article Metrics

Back to TopTop